Japan’s Annual Medical Cost Cap: What Must Be Paid Before Reimbursement?

An examination of the August 2026 revision through one income category for people under 70, focusing on monthly and annual limits and reimbursement.

August 10, 2026Updated: November 5, 2026Naoya YokotaAbout 10 min read

Read current MHLW and Kyokai Kenpo sources on Japan’s high-cost medical benefit. Two diagrams distinguish monthly and annual limits, payment timing and modelled results from actual experience.

Health & Medicine Social Insurance Policy Japan

X Facebook Threads

TL;DR

Monthly limits and annual reimbursement use different periods
Distinguish the monthly formula from repeated-month conditions
Modelled results are not observed patient outcomes

The image is an AI-generated fictional medical consultation setting, not a photograph documenting an actual patient or medical institution.

This article gives general information about published arrangements, not an individual benefit determination or legal advice. Confirm eligible costs and categories with the insurer or relevant official office; consult a qualified lawyer about an individual legal judgment.

What Is Happening

Read the limits with eligible costs and periods

Read monthly and annual limits together

Over what period should a household's continuing medical costs be assessed? Higher monthly payments can coexist with a lower annual burden after reimbursement. Conversely, creating an annual limit does not establish that everyone's burden falls. Both the benefit calculation and the timing of money leaving the household matter.

The , or MHLW, explains that monthly limits were revised and an annual limit introduced from August 2026. Finer income categories from August 2027 are a further stage. Distinguishing implemented provisions from future ones is a starting point for comparison.

This article mainly considers people under 70 whose standard monthly remuneration under employment-based health insurance is ¥280,000 to ¥500,000. The approximate annual-income label of ¥3,700,000 to ¥7,700,000 (¥3.7 million to ¥7.7 million) is a guide, rather than enough to determine someone's category. National Health Insurance uses different income criteria. Age, insurance and income conditions need to be matched before comparing figures.

The annual limit is not one amount for everyone

For this category, the , known as Kyokai Kenpo, lists an annual limit of ¥530,000. Other income and age categories have other amounts. This is not a ceiling on all medical spending for everyone.

MHLW defines the annual period as August through the following July. It is neither January through December nor any twelve months chosen from the start of treatment. A figure needs its eligible costs and period alongside it. The same word, annual, does not mean that different programmes share one accounting period.

Background & Context

Distinguish formulas, repeated months and aggregation

A base-amount difference is not the calculation difference

Kyokai Kenpo's tables change this category's monthly formula from ¥80,100 + (total medical costs − ¥267,000) × 1% to ¥85,800 + (total medical costs − ¥286,000) × 1%. Total medical costs here mean the full insured treatment cost, rather than only the patient's counter payment.

Holding total medical costs at ¥1 million for a month without qualifying for the reduced cap for repeated months gives ¥87,430 under the old formula and ¥92,940 under the new one. The difference is ¥5,510. This is the author's arithmetic comparison of fixed conditions, rather than a survey of actual payments. Comparing only the base amounts gives ¥5,700 and omits the change in the subtracted amount.

It would also be incorrect to infer that everyone pays ¥5,510 more every month. Reaching the monthly limit, repeated-month eligibility and annual reimbursement affect the result. Comparing formulas helps explain a provision, but cannot establish the number or share of people whose burdens rise without examining their circumstances.

Repeated-month eligibility does not count only consecutive treatment

The reduced cap for repeated months applies from the fourth qualifying month when there have been at least three qualifying months in the rolling twelve-month assessment, including the current month. MHLW illustrates how the assessment window moves with each month. It counts qualifying months, rather than individual visits, and does not require treatment to occur every month.

For the example category the reduced limit remains ¥44,400. Kyokai Kenpo explains that this applies under the same insurer and insured person. Counts do not carry over in circumstances such as changing insurers. General guidance alone cannot determine how an individual's past treatment is counted.

Month and repeated months

Monthly limit: Eligible costs in the same month
Repeated months: Qualifying months in the rolling twelve-month window
Check: Insurer and eligibility continuity

Annual limit

Period: August through the following July
Amount: Accumulated eligible personal costs
Benefit: Reimbursement from the insurer

A framework based on MHLW and Kyokai Kenpo guidance. Age, income, insurance and aggregation conditions affect eligibility.

Figure 1. Monthly, repeated-month and annual rules count different things

Adding every receipt is not enough

Kyokai Kenpo excludes the additional non-insured portion of combined treatment and personal charges for inpatient meals or living costs. An annual limit and a limit covering every expense associated with treatment are different things. Conditions of daily life around treatment cannot be read from an insured-cost table alone.

Aggregation also has conditions. Medical and dental treatment, and inpatient and outpatient care, are calculated separately even at one institution. For people under 70, eligible amounts of at least ¥21,000 in each calculation category can be aggregated. Prescription pharmacy charges have a stated relationship to the prescribing institution's charges. Kyokai Kenpo applies the same aggregation conditions to annual applications, rather than allowing every annual receipt to be added unconditionally.

Reading the Structure

Examine payment timing and the scope of projections

Separate the annual burden from payments before reimbursement

MHLW's explains that amounts above the annual limit are initially paid at the institution and subsequently reimbursed by the insurer. Reaching the annual limit should not be described as automatically stopping all further counter payments that day.

Kyokai Kenpo states that annual-limit applications begin in August 2027. At the November 4, 2026 check, it asks readers to wait for the form's publication. This is not evidence that annual benefits have already been received before the first accounting period ends. An announced process needs to be distinguished from records of applications and payments actually completed.

A separate arrangement can limit counter payments above the monthly ceiling. MHLW describes using a registered health-insurance My Number card or a certificate of applicable limit. Using that monthly arrangement does not mean annual excess costs are processed automatically at the counter. Aggregated costs and treatment at several institutions also require returning to the insurer's guidance.

What the provisions show

Limit: Eligible costs within each category
Calculation: Monthly and annual benefits
Reimbursement: Benefit for eligible excess costs

What experience needs to show

Payment: When and how much was paid?
Process: Who could be contacted and how?
Receipt: When did the benefit arrive?

The author's distinction between programme limits and household payments over time. An announced reimbursement is not a completed payment.

Figure 2. Read annual cost limits separately from the timing of payments

Place payment records beside benefit records

The author's proposed approach places eligible payments made in each month and benefits received later in separate fields. Subtracting reimbursement from an annual total alone removes the sequence of intermediate payments. For example, an expected annual reimbursement that has not arrived would not be entered as a benefit already received. This is a proposal for distinguishing money paid from money returned within a record, rather than a worksheet determining an individual's entitlement or payment amount.

Each field also needs a consistent meaning. Counter payments, costs after a monthly benefit, and costs after annual reimbursement should not be mixed under one heading for personal costs: the same benefit could otherwise be subtracted twice. The proposed record would identify the treatment month covered, the receipt date, and whether the benefit had already been reflected elsewhere. Expected amounts would remain separate from confirmed ones. Where a monthly limit was already applied at the counter, that reduction would not also be entered as cash subsequently returned. This distinguishes entitlement calculations from actual money flows.

Someone helping with records could match received benefits to insurer notices without independently deciding entitlement from receipts. If a payment covers several treatment months, its receipt month alone would not identify those months. Leaving unresolved entries marked as unconfirmed could prevent assumptions made simply to complete a household record. This is a proposed recording method, not a substitute for the insurer’s assessment.

The scope of costs also belongs in a comparison. If one person's record includes non-insured charges and meal costs while another contains only eligible amounts, their difference cannot be read as an effect of the revision. A change in insurer or income category during the period also needs to remain visible. Comparing matched eligible costs and comparing all spending associated with treatment answer different questions; each requires a stated purpose and consistent boundaries.

Payment dates and benefit receipt dates still do not explain every effect on daily life. Whether someone could work during treatment, how income changed and whether time for consultation was available are additional conditions. An assessment can include what the person wishes to share about those circumstances, without assuming a single explanation for differences in payment. Even where a change in treatment is recorded, attributing it solely to a revised amount requires examining the person's account and clinical circumstances. This proposed method does not establish that patients currently avoid necessary care because of this revision.

Applying a formula is different from observing results

MHLW's current show both lower and higher annual burdens. An annual reimbursement example without repeated-month eligibility differs from an example with only one high-cost month. Selecting either cannot establish improvement or deterioration for all patients.

The single-month example notes that medical-cost data from a past year at Kyokai Kenpo were processed, with revised personal costs estimated by the secretariat. Actual medical data can underpin a calculation without making the resulting revised amount an observation after implementation. It is not a follow-up survey of payments after August 2026. Omitting that note would turn a modelled result into a reported post-implementation payment.

The same distinction matters for fiscal effects. The describes medical-cost changes estimated with an empirical formula as requiring subsequent verification. A spending calculation does not establish that necessary care was preserved. Spending and access still need separate examination.

Participation and receipt are separate questions

Patient groups, insurers, and labour and employer representatives participated in the 's 2025 discussions. Participation alone does not establish that every person's circumstances were reflected or that everyone accepted the result. The discussion process and experience after implementation require separate attention.

The existence of a benefit leaves a question about whether eligible people received it. This article proposes examining whether an explanation could be read, a category confirmed, the insurer contacted, and reimbursement received. This avoids reducing every reason for non-receipt to an individual's lack of knowledge. It is a proposed assessment framework, rather than a finding about the present prevalence of non-receipt.

Reference Books

医療保険制度の再構築:失われつつある「社会保険としての機能」を取り戻す（外部サイト、新しいタブで開きます） (Rebuilding the Health Insurance System: Recovering Its Social Insurance Function) lists insurer autonomy, changing work arrangements, National Health Insurance, benefits and burdens among its contents. It offers a reading entry beyond one limit figure into insurance's role. Only the public description, contents and bibliography were reviewed; the whole book was not read, and it is not evidence of this revision's effects. The link is an Amazon Associates advertising link.

Remaining Questions

Match populations and periods; examine changes in daily life and unresolved conditions.

Whose burden is measured, over which period? People reaching monthly limits and those accumulating smaller continuing payments experience the rules differently. Annual comparisons need matched eligible costs, income, age and insurance conditions. A category example cannot represent patients nationwide. Counts of people paying more or less may still miss the circumstances in which treatment continues and experiences obscured by averages.

Who can assess payments before reimbursement? A capped annual total does not answer whether intermediate payments can be made. Treatment-related income changes and living costs also matter. An application timetable alone cannot describe the household's outlook. A listed contact, a successful consultation and a benefit received are separate events. Explaining the rules should not become an instruction to rearrange medically necessary treatment simply to fit a payment calendar.

What should be checked after implementation? Modelled figures, treatment received, payments and reimbursements are different records. Lower spending alone cannot establish that necessary care arrived. Alongside listening to patients, ways are needed to understand conditions preventing access without demanding unwanted disclosure of personal circumstances. How monthly and annual limits supported the prospect of continuing treatment remains a question to revisit through actual experience. Who sustains this review, and how can it hear from people who did not receive a benefit? Time for consultation and the option not to answer deserve attention so gathering evidence does not create another burden.

References

Guidance for Users of High-Cost Medical Expense Benefits — MHLW (2026). Updated July 31, 2026; checked November 4

High-Cost Medical Expense Benefits — Japan Health Insurance Association (2026). Old and revised tables and annual application guidance, checked November 4

Reference Materials on High-Cost Medical Expense Benefits — MHLW (2026). Relevant tables and methodological notes in the 29-page reference checked

High-Cost Medical Expense Benefit Revisions: Leaflet — MHLW (2026). Both physical pages reviewed as images

Expert Committee on High-Cost Medical Expense Benefits — MHLW (2025). Meeting list and membership in reference materials reviewed

Ministerial Press Conference Summary, September 15, 2026 — MHLW (2026). Conference text distinguishes projections and subsequent verification

医療保険制度の再構築 — Kazuhiko Nishizawa (2020). Keio University Press, ISBN978-4-7664-2707-3; public description, contents and bibliography only

医療保険制度の再構築:失われつつある「社会保険としての機能」を取り戻す

西沢和彦 / Kazuhiko Nishizawa (2020)

Related reading from public bibliography, publisher description and contents. Whole book unread; not evidence of current benefits or policy effects.

View on AmazonPR

Statistics cited in this article

1Japan Health Insurance Association: high-cost medical benefit（August 2026 to July 2027） Open source
2MHLW, Reference Materials on High-Cost Medical Expense Benefits, August 2026–July 2027 table（August 2026 to July 2027） Open source
3MHLW, Reference Materials on High-Cost Medical Expense Benefits: costs and annual limits（2026） Open source
4Japan Health Insurance Association, High-Cost Medical Expense Benefits（Through July 2026 and August 2026 to July 2027） Open source

Questions to Reflect On

Which category and period are being compared?
What payments continue before reimbursement?
Are projections separated from treatment and benefits received?

X Facebook Threads

Ask about this article

Get new columns by email

1-2 social structure analysis columns per week. Free to subscribe.

Join ISVD's activities?

Sign up to receive the latest research and activity reports. Feel free to reach out about collaboration or project participation.

Join Contact Us

Support ISVD’s research and activities

Support ISVD’s research and publications with JPY5,000 per year. There is no automatic renewal.

Become a supporting member About supporting membership

Menu

About

Activities & Support

Platforms

Join & Contact

Japan’s Annual Medical Cost Cap: What Must Be Paid Before Reimbursement?